Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

FDA Commissioner Marty Makary announced a phaseout of eight synthetic food dyes—including Red 40—by 2026. The FDA will set ...

Sedana Medical AB (publ) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's application to initiate an Early Access Program for its investigational inhaled sed ...

Short Summary The EU, UK, and USA each have distinct and evolving regulatory systems for medicines and medical devices, involving strict approval, surveillance, and market access requirements managed ...

As per Future Market Insights’ latest industry analysis, the valuation for the global clot busting drugs market is estimated to be around USD 28.8 Billion in 2022 and is projected to exhibit a CAGR ...

Tuna is awash in helpful nutrients like iron and omega-3 fatty acids—not to mention delicious in sushi, salads, and ...

Non-retail Specialty Drugs Market forecast to 2035 highlights market size and key therapeutic trends. It focuses on growing demand for complex therapies through specialized healthcare channels.

The FDA is planning to eliminate six commonly used synthetic, petroleum-based food dyes from the American food supply by the end of 2026.

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

Health campaign: Robert F. Kennedy Jr., the secretary of health and human services, escalated his fight against the food ...

As a selective monoamine oxidase B (MAO-B) inhibitor, XADAGO offers a unique mechanism of action that complements traditional therapies, pote ...